Income Statement

Income Statement

  Year Ending Dec 2018 (Update) Year Ending Dec 2017 (Update) Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Update)
Net Sales 21.21 12.13 7.75 7.22
Revenue 21.21 12.13 7.75 7.22
Total Revenue 21.21 12.13 7.75 7.22
Cost of Revenue 9.00 6.17 3.41 3.62
Cost of Revenue, Total 9.00 6.17 3.41 3.62
Gross Profit 12.21 5.95 4.34 3.60
Selling/General/Administrative Expense 2.95 2.37 1.73 1.11
Labor & Related Expense 8.34 5.05 3.48 2.37
Advertising Expense 0.30 0.21 0.30 0.05
Selling/General/Administrative Expenses, Total 11.60 7.63 5.51 3.53
Depreciation 0.32 0.32 0.24 0.33
Depreciation/Amortization 0.32 0.32 0.24 0.33
Litigation -- -- -- --
Other Unusual Expense (Income) -- 0.00 0.05 0.00
Unusual Expense (Income) -- 0.00 0.05 0.00
Other Operating Expense 0.11 0.13 0.13 0.33
Other Operating Expenses, Total 0.11 0.13 0.13 0.33
Total Operating Expense 21.03 14.26 9.33 7.82
Operating Income 0.18 -2.13 -1.58 -0.60
Interest Expense - Non-Operating -- -- 0.00 0.00
Interest Expense, Net Non-Operating -- -- 0.00 0.00
Interest Income, Non-Operating 0.05 0.03 0.04 0.00
Interest/Investment Income, Non-Operating 0.05 0.03 0.04 0.00
Interest Income (Expense), Net-Non-Operating, Total 0.05 0.03 0.04 0.00
Net Income Before Taxes 0.23 -2.10 -1.54 -0.60
Income Tax – Total 0.00 0.00 0.00 --
Income After Tax 0.23 -2.10 -1.54 -0.60
Net Income Before Extraordinary Items 0.23 -2.10 -1.54 -0.60
Net Income 0.23 -2.10 -1.54 -0.60
Income Available to Common Excluding Extraordinary Items 0.23 -2.10 -1.54 -0.60
Income Available to Common Stocks Including Extraordinary Items 0.23 -2.10 -1.54 -0.60
Basic Weighted Average Shares 10.83 9.82 9.90 8.19
Basic EPS Excluding Extraordinary Items 0.02 -0.21 -0.16 -0.07
Basic EPS Including Extraordinary Items 0.02 -0.21 -0.16 -0.07
Dilution Adjustment -- -- -- --
Diluted Net Income 0.23 -2.10 -1.54 -0.60
Diluted Weighted Average Shares 11.86 9.82 9.90 8.19
Diluted EPS Excluding Extraordinary Items 0.02 -0.21 -0.16 -0.07
Diluted EPS Including Extraordinary Items 0.02 -0.21 -0.16 -0.07
DPS - Common Stock Primary Issue -- -- -- 0.00
Gross Dividends - Common Stock 0.00 0.00 0.00 0.00
Total Special Items -- 0.00 0.05 0.00
Normalized Income Before Taxes 0.23 -2.10 -1.49 -0.60
Effect of Special Items on Income Taxes -- 0.00 0.00 0.00
Income Taxes Excluding Impact of Special Items 0.00 0.00 0.00 0.00
Normalized Income After Taxes 0.23 -2.10 -1.49 -0.60
Normalized Income Available to Common 0.23 -2.10 -1.49 -0.60
Basic Normalized EPS 0.02 -0.21 -0.15 -0.07
Diluted Normalized EPS 0.02 -0.21 -0.15 -0.07
Amortization of Intangibles, Supplemental 0.26 0.28 0.22 0.33
Depreciation, Supplemental 0.06 0.05 0.02 0.00
Interest Expense, Supplemental -- -- 0.00 0.00
Rental Expense, Supplemental 0.08 0.08 0.08 0.06
Stock-Based Compensation, Supplemental 1.86 0.90 0.56 0.33
Advertising Expense, Supplemental 0.30 0.21 0.30 0.05
Audit-Related Fees, Supplemental 0.12 0.03 0.04 0.04
Audit-Related Fees 0.02 0.00 0.00 0.00
Tax Fees, Supplemental 0.00 0.00 0.00 0.00
All Other Fees Paid to Auditor, Supplemental 0.00 0.00 0.00 0.00
Gross Margin 57.56 49.09 55.99 49.84
Operating Margin 0.85 -17.56 -20.40 -8.27
Pretax Margin 1.07 -17.35 -19.86 -8.24
Effective Tax Rate 0.00 -- -- --
Net Profit Margin 1.07 -17.35 -19.86 -8.24
Normalized EBIT 0.18 -2.13 -1.53 -0.60
Normalized EBITDA 0.50 -1.81 -1.29 -0.26

In millions of USD (except for per share items)

Copyright Thomson Reuters Corporation

Photograph of the team looking at their EHR services software.

Company

Get the full story on our people, culture and career opportunities.

Photograph of a laptop that is used to look at electronic healthcare records.

Services

Find the specific services now available from OptimizeRx.

Photograph of business partners.

Partners

Explore the many benefits of partnering with OptimizeRx.

Photograph of resources used by healthcare professionals.

Resources

Count on us to help with the information and answers you need.